Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$156,853,254
+$34,084,588 QoQ
Shares Held
9,877,409
+8.7% QoQ
Ownership
0.860%
of shares outstanding
% of Portfolio
3.13%
of 13F equity value
Holder Rank
#19
of 1,020 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GLENVIEW CAPITAL MANAGEMENT, LLC holds $329,000,617 across 2 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (47.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
5,081,091 | $172,147,363 | |
| 2 | VTRS |
Viatris Inc
This page
|
9,877,409 | $156,853,254 |
All Filings in VTRS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $156,853,254 | 9,877,409 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $122,768,666 | 9,087,244 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $138,036,187 | 11,087,244 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $81,651,081 | 8,247,584 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $73,650,925 | 8,247,584 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $73,973,533 | 8,492,943 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $116,075,321 | 9,323,319 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $87,909,828 | 7,571,906 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $69,039,532 | 6,494,782 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $61,395,468 | 5,141,999 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $65,684,459 | 6,065,047 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||